Trial intelligence / Profile preview

Impact of ketorolac and pethidine on acute pain control and postoperative complications after hemorrhoidectomy

IRCT20140519017756N44Phase 2Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
May 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ketorolac and pethidine in hemorrhoid (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Acute postoperative pain control and Postoperative complications. Started May 2018; status: completed.

02

Drugs

ketorolacpethidine
03

Conditions

hemorrhoid

Beyond the preview

Go deeper on IRCT20140519017756N44.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20140519017756N44.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call